Finland dominated this week's deal flow. Four of the six biggest Nordic stories came out of Helsinki or Espoo, led by Verda's EUR 100 million raise for AI cloud infrastructure, a company that's already cash flow positive and doubling its revenue run rate. Sweden showed up differently: not with fundraises, but with exits and acquisitions. Roche dropped up to $595 million on Lund's SAGA Diagnostics, validating years of quiet cancer detection work. Legora, fresh off its $550 million Series D, swallowed Stockholm's Qura to build the definitive legal AI research platform. The cleantech corner is alive too. A Finnish startup called TheStorage is heating factories with sand, which sounds like a children's science project until you realize 80% of industrial heat still runs on fossil fuels. And Proteins.1 wants to detect diseases before they show symptoms, using single-molecule protein detection that's up to 1,000 times more sensitive than current tools.

Verda (Helsinki) raised EUR 100 million ($117M) in equity and debt to expand its AI cloud infrastructure. Led by Lifeline Ventures with Tesi, byFounders, and Varma. Revenue run rate hit EUR 51.3 million in Q1. Cash flow positive. Plans 100+ hires and expansion across Europe, US, and Asia. The company runs 100% renewable data centers in Finland as an NVIDIA Preferred Partner.

Realm (Helsinki) closed a $4.5 million seed round led by Frontline Ventures and HubSpot Ventures. Angel investors include Slack co-founder Cal Henderson and Deel co-founder Alex Bouaziz. The company automates enterprise deal materials like RFP responses, with 70-80% of outputs approved without edits. Founded by ex-Slush leaders.

TheStorage (Finland) raised EUR 3.6 million in seed funding led by Voima Ventures to scale its sand-based thermal energy storage system. Total funding now stands at EUR 5.8 million. The technology converts renewable electricity into heat stored in moving sand, claiming up to 70% energy bill reductions for industrial customers.

Proteins.1 (Espoo, Finland) raised EUR 4.7 million in pre-seed funding led by Lifeline Ventures. The VTT spinout has developed single-molecule protein detection technology claiming up to 1,000x sensitivity over existing platforms. Initial focus on research-use-only applications in oncology, neurology, and immunology.

Roche is acquiring SAGA Diagnostics (Lund, Sweden) for up to $595 million through its subsidiary Foundation Medicine. SAGA's Pathlight platform combines whole genome sequencing and digital PCR for ultra-sensitive cancer recurrence monitoring. Already covered by Medicare for early-stage breast cancer. Expected to close Q3 2026.

Legora acquired Stockholm's Qura, an AI-native legal research startup covering 27 jurisdictions with 40% month-over-month revenue growth. Second acquisition in two months for the $5.55 billion legal tech giant. Qura's team will focus on US expansion.

That's your Friday briefing. Six stories, two countries, and well over $800 million in capital movement across AI infrastructure, legal tech, cancer diagnostics, cleantech, enterprise sales, and deep tech diagnostics. The Nordic ecosystem doesn't slow down on Fridays. Neither should you.